FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jawed Fareed

Research Profile

Chemicals & Drugs

Concepts & Ideas

Physiology

Blood Coagulation

Disorders

Thrombocytopenia

Co-author Network

Publications

TOP 3
Omer Iqbal; Nasir Sadeghi; Joel Sugar; Daneyal Syed; Samir Vira; Edward Campbell; Jawed Fareed; Robert Feder; George Fisher; David Freeman; Charles Bouchard
Increased expression of secreted frizzled-related protein-1 and microtubule-associated protein light chain 3 in keratoconus.
Giulianna P V Andrade; SF Chavante; Airton A de Souza Junior; Jawed Fareed; Debra A Hoppensteadt; Marcelo A Lima; Fernanda W Oliveira; Hugo A O Rocha; Elizeu A Santos; Helena B Nader
A heparin-like compound isolated from a marine crab rich in glucuronic acid 2-O-sulfate presents low anticoagulant activity.
Marcelo A Lima; Guilherme L Sassaki; Christian Viskov; Renan P Cavalheiro; Eduardo H C de Farias; Jawed Fareed; Angel L Gray; Frederic Herman; Debra Hoppensteadt; Helena B Nader
Ultra-low-molecular-weight heparins: precise structural features impacting specific anticoagulant activities.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jawed Fareed (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Omer Iqbal; Nasir Sadeghi; Joel Sugar; Daneyal Syed; Samir Vira; Edward Campbell; Jawed Fareed; Robert Feder; George Fisher; David Freeman; Charles Bouchard
Increased expression of secreted frizzled-related protein-1 and microtubule-associated protein light chain 3 in keratoconus.
Cornea 2013;32(5):702-7.
2013: Giulianna P V Andrade; SF Chavante; Airton A de Souza Junior; Jawed Fareed; Debra A Hoppensteadt; Marcelo A Lima; Fernanda W Oliveira; Hugo A O Rocha; Elizeu A Santos; Helena B Nader
A heparin-like compound isolated from a marine crab rich in glucuronic acid 2-O-sulfate presents low anticoagulant activity.
Carbohydrate polymers 2013;94(1):647-54.
2013: Marcelo A Lima; Guilherme L Sassaki; Christian Viskov; Renan P Cavalheiro; Eduardo H C de Farias; Jawed Fareed; Angel L Gray; Frederic Herman; Debra Hoppensteadt; Helena B Nader
Ultra-low-molecular-weight heparins: precise structural features impacting specific anticoagulant activities.
Thrombosis and haemostasis 2013;109(3):471-8.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Key questions to be answered.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):224-5.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Cost-effectiveness of prevention and treatment of VTE.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):220-3.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Periprocedural management of antithrombotic therapy and use of bridging anticoagulation.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):215-9.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Prevention of postthrombotic syndrome.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):213-5.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Superficial vein thrombosis.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):208-13.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Treatment for patients with cancer.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):206-8.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Surgical thrombectomy.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):205-6.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Inferior vena cava filters.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):204-5.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Thrombolytic therapy.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):198-204.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Diagnosis and anticoagulant treatment.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):187-98.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Thrombophilia.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):177-87.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Combined modalities in surgical patients.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):177.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Patients with cancer.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):172-6.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Critical care medical patients.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):171-2.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Medical patients.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):163-71.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Neurosurgery.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):161-3.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Burns.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):161.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Orthopedic surgery and trauma.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):141-60.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Gynecology and obstetrics.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):135-41.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Urologic surgery.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):133-4.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
General, vascular, bariatric, and plastic surgical patients.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):122-33.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
The problem and the need for prevention.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):121-2.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Introduction.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):118-20.
2013: Andrew Nicolaides; Russell D Hull; Jawed Fareed
Prevention and treatment of venous thromboembolism: international consensus statement (guidelines according to scientific evidence).
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013;19(2):116-8.
2013: Jawed Fareed; Walter Jeske; Indermohan Thethi
Metabolic differences of current thienopyridine antiplatelet agents.
Expert opinion on drug metabolism & toxicology 2013;9(3):307-17.
2012: Jeanine M Walenga; V Escalante; Jawed Fareed; Debra Hoppensteadt; Walter P Jeske; Mamdouh Bakhos
Thromboelastographic evaluation of blood coagulation in the presence of branded and generic enoxaparins.
International angiology : a journal of the International Union of Angiology 2012;31(6):517-25.
2012: Indermohan Thethi; Vinod Bansal; Debra Hoppensteadt; Hussein Khan; Jawed Fareed
Assessment of levels of vascular endothelial growth factor in patients with ESRD and its possible role in cardiovascular morbidity and mortality.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18(5):534-7.
2012: Marcelo A Lima; Nasir Sadeghi; Guilherme L Sassaki; Renan P Cavalheiro; Eduardo H C de Farias; Jawed Fareed; Tarsis F Gesteira; Angel Gray; Debra Hoppensteadt; Helena B Nader
Structural and pharmacological profile of generic enoxaparins used in Brazil.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18(4):379-86.
2012: Indermohan Thethi; Bruce Lewis; Jawed Fareed
Oral factor Xa and direct thrombin inhibitors: a clinical perspective.
Journal of burn care & research : official publication of the American Burn Association 2012;33(4):453-61.
2012: Rodrigo I Bouças; Renan P Cavalheiro; Jawed Fareed; Debra Hoppenstead; Thais R Jarrouge-Bouças; Marcelo A Lima; Fabio A Moraes; Ivarne L S Tersariol; Edvaldo S Trindade; Helena B Nader
Glycosaminoglycan backbone is not required for the modulation of hemostasis: effect of different heparin derivatives and non-glycosaminoglycan analogs.
Matrix biology : journal of the International Society for Matrix Biology 2012;31(5):308-16.
2012: Nasir Sadeghi; Saayi Krushna Gadham Setty; He Zhu; Josephine Cunanan; Debra Hoppensteadt; Jawed Fareed
Cross-reactivity of various thrombin products with anti-rabbit antibodies to bovine, human, and recombinant thrombin.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18(3):243-8.
2012: Walter Jeske; Hussein Khan; Evangelos Litinas; Debra Hoppensteadt; Jawed Fareed
A comparison of the pharmacodynamic behavior of branded and biosimilar enoxaparin in primates.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18(3):294-8.
2012: Anna De La Peña; Indermohan Thethi; Jawed Fareed; Sarkis Morales-Vidal; Michael J Schneck; Danielle Shafer
Ischemic stroke in the setting of chronic immune thrombocytopenia in an elderly patient--a therapeutic dilemma.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18(3):324-6.
2012: Marc Cohen; Walter P Jeske; Gilles Montalescot; Jose C Nicolau; Jawed Fareed
US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins.
Journal of thrombosis and thrombolysis 2012;33(3):230-8.
2012: Angel Gray; Walter Jeske; Evangelos Litinas; Jawed Fareed; Debra Hoppensteadt
Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012;18(2):166-73.
2012: Ghanshyam N Pandey; Xinguo Ren; Hooriyah S Rizavi; Rosalinda C Roberts; Robert R Conley; Jawed Fareed; Debra A Hoppensteadt; Yogesh Dwivedi
Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims.
Journal of psychiatric research 2012;46(1):57-63.
2011: Justin W Griffin; William J Hopkinson; Michael R Lassen; Evangelos Litinas; Indermohan Thethi; Jawed Fareed
Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(6):567-71.
2011: Rachael Davis; Vinod Bansal; Debra Hoppensteadt; Evangelos Litinas; Kelly Nelson; Indermohan Thethi; Jawed Fareed
Upregulation of inflammatory mediators in end-stage renal disease as measured using biochip array technology.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(6):E218-23.
2011: Craig A Paterson; Glenn C Pixton; Howard M Proskin; Bruce Cronstein; Jawed Fareed; Joseph M Massaro; Mark Morasch; Frederick A Ofosu
Immune responses associated with perioperative exposure and reexposure to topical bovine thrombin do not impair hemostasis.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(6):620-32.
2011: Saudur Rahman; Indermohan Thethi; Mark Cichon; Josephine Cunanan; Debra Hoppensteadt; Walter Jeske; Jawed Fareed
Upregulation of microparticles in DIC and its impact on inflammatory processes.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(6):E202-4.
2011: Walter P Jeske; Lauren Myers; Hélène Rigal; Alain Bayol; Josephine Cunanan; Jawed Fareed; Angel Gray; Debra Hoppensteadt; Jeanine M Walenga; Christian Viskov
A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparin.
Thrombosis research 2011;128(4):361-7.
2011: Kelly Nelson; Indermohan Thethi; Josephine Cunanan; Debra Hoppensteadt; Randeep Bajwa; Jawed Fareed; Vinod Bansal
Upregulation of surrogate markers of inflammation and thrombogenesis in patients with ESRD: pathophysiologic and therapeutic implications.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(3):302-4.
2011: Gundu H R Rao; Indermohan Thethi; Jawed Fareed
Vascular disease: obesity and excess weight as modulators of risk.
Expert review of cardiovascular therapy 2011;9(4):525-34.
2011: Indermohan Thethi; Jawed Fareed
Newer oral anticoagulants: a promising future.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(2):235.
2011: Walter P Jeske; Jeanine M Walenga; Meyer M Samama; Debra Hoppensteadt; Myttle Mayuga; Jawed Fareed
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levels.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2011;22(3):206-10.
2011: Eduardo Ramacciotti; Melanie Clark; Nasir Sadeghi; Debra Hoppensteadt; Indermohan Thethi; Marise Gomes; Jawed Fareed
Review: contaminants in heparin: review of the literature, molecular profiling, and clinical implications.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(2):126-35.
2011: Evi Kalodiki; Jawed Fareed
New and generic anticoagulants and biosimilars: safety considerations.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(2):136-9.
2011: Jawed Fareed; Craig A Paterson; Sheila M Crean
A multicenter pilot study to estimate the prevalence of bovine and human coagulation antibodies in the general US population.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(2):164-70.
2011: Lothar Heilmann; Martin Schorsch; Thomas Hahn; Jawed Fareed
Antiphospholipid syndrome and pre-eclampsia.
Seminars in thrombosis and hemostasis 2011;37(2):141-5.
2011: Marise Gomes; Eduardo Ramacciotti; Debra Hoppensteadt; Jeanine M Walenga; Bruce Lewis; Indermohan Thethi; Jawed Fareed
An open label, non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(1):66-9.
2011: Mohit Bhandari; Frederick A Ofosu; Nigel Mackman; Craig Jackson; Cataldo Doria; John E Humphries; Sateesh C Babu; Thomas L Ortel; David Hoffman Van Thiel; Jeanine M Walenga; Rakesh Wahi; Kevin Hong To Teoh; Jawed Fareed
Safety and efficacy of thrombin-JMI: a multidisciplinary expert group consensus.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2011;17(1):39-45.
2011: Jawed Fareed; Cafer Adiguzel; Indermohan Thethi
Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism.
Thrombosis journal 2011;9(1):5.
2011: Marcelo A Lima; Tim Rudd; Eduardo H C de Farias; Lyvia F Ebner; Tarsis F Gesteira; Lauro M de Souza; Aline Mendes; Carolina R Córdula; João R M Martins; Debra Hoppensteadt; Jawed Fareed; Guilherme L Sassaki; Edwin A Yates; Ivarne L S Tersariol; Helena B Nader
A new approach for heparin standardization: combination of scanning UV spectroscopy, nuclear magnetic resonance and principal component analysis.
PloS one 2011;6(1):e15970.
2011: Zhenling Liu; Zhongping Xiao; Sayaka Masuko; Wenjing Zhao; Eric Sterner; Vinod Bansal; Jawed Fareed; Jonathan S Dordick; Fuming Zhang; Robert J Linhardt
Mass balance analysis of contaminated heparin product.
Analytical biochemistry 2011;408(1):147-56.
2010: Marise Gomes; Eduardo Ramacciotti; Evangelos Litinas; Jawed Fareed
[Concerns on generic enoxaparin use in acute coronary syndrome].
Arquivos brasileiros de cardiologia 2010;95(4):551-2.
2010: Walter P Jeske; Jawed Fareed; Debra A Hoppensteadt; Bruce Lewis; Jeanine M Walenga
Pharmacology of argatroban.
Expert review of hematology 2010;3(5):527-39.
2010: Debra Hoppensteadt; Michael Morris; Jawed Fareed
Cross-reactivity of rabbit anti-bovine prothrombin/thrombin IgGs with bovine factor V/Va-related antigens.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(5):522-8.
2010: Indermohan Thethi; Harry Messmore; Jawed Fareed
Response variation in patients treated with clopidogrel.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(4):483-4.
2010: Jacqueline Kuziej; Evangelos Litinas; Debra A Hoppensteadt; Dahui Liu; Jeanine M Walenga; Jawed Fareed; Walter Jeske
In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(4):377-86.
2010: Debra Hoppensteadt; Josephine Cunanan; Jawed Fareed
Cross-reactivity of rabbit anti-bovine thrombin IgGs with human alpha-thrombin and a recombinant version of human thrombin (Recothrom).
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(3):273-80.
2010: Jawed Fareed; Debra A Hoppensteadt; Eduardo Ramacciotti; Russell D Hull
Contaminants in heparins: are all facts known?
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(3):242-3.
2010: Shaker A Mousa; Walter P Jeske; Jawed Fareed
Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(2):170-6.
2010: Jonathan R Genzen; Jawed Fareed; Debra Hoppensteadt; Viji Kurup; Paul Barash; Michael Coady; Yan Yun Wu
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis.
Transfusion 2010;50(4):801-7.
2010: Jawed Fareed; Russell Hull
Apixaban to prevent venous thromboembolism after knee replacement.
Lancet 2010;375(9717):779-80.
2010: Michael John Knesek; Evangelos Litinas; Cafer Adiguzel; William Hopkinson; Debra Hoppensteadt; Michael Lassen; Jawed Fareed
Inflammatory biomarker profiling in elderly patients with acute hip fracture treated with heparins.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(1):42-50.
2010: Debra A Hoppensteadt; Brian Neville; Christopher Schultz; Walter Jeske; Wolfram Raake; Jawed Fareed
Comparative studies on the topical administration of mucopolysaccharide and heparin ointments in nonhuman primates.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2010;16(1):13-20.
2010: Shaker A Mousa; Walter P Jeske; Jawed Fareed
Prasugrel: a novel platelet ADP P2Y(12) receptor antagonist.
Methods in molecular biology (Clifton, N.J.) 2010;663():221-8.
2010: Elizabeth McGeehan; Karen Wielgus; Lee Cera; Farshid Azarafrooz; Rose Buesing; Jean Dubach; Jawed Fareed
Coagulation profiling of random-source cats.
Journal of the American Association for Laboratory Animal Science : JAALAS 2010;49(1):27-30.
2010: OFFER EREZ; Roberto Romero; Eduard Vaisbuch; Juan Pedro Kusanovic Pivcevic; Shali Mazaki-Tovi; Tinnakorn chaiworapongsa; Francesca Gotsch; Jawed Fareed; Debra Hoppensteadt; Nandor Gabor Than; Bo Hyun Yoon; Samuel Edwin; Zhong Dong; Jimmy Espinoza; Moshe Mazor; Sonia S Hassan
High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2010;23(1):23-33.
2009: He Zhu; Debra Hoppensteadt; Omer Iqbal; Evangelos Litinas; Cafer Adiguzel; Jawed Fareed
Relative purity of different bovine thrombin preparations.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(6):681-8.
2009: Cafer Adiguzel; Omer Iqbal; Muzaffer Demir; Jawed Fareed
European community and US-FDA approval of recombinant human antithrombin produced in genetically altered goats.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(6):645-51.
2009: Cinara L Echart; Barbara Graziadio; Simona Somaini; Laura I Ferro; Paul G Richardson; Jawed Fareed; Massimo Iacobelli
The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(8):627-34.
2009: Cafer Adiguzel; Omer Iqbal; Debra Hoppensteadt; Walter Jeske; Josephine Cunanan; Evangelos Litinas; Jeanine M Walenga; Jawed Fareed
Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexide.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(5):501-11.
2009: OFFER EREZ; Francesca Gotsch; Shali Mazaki-Tovi; Eduard Vaisbuch; Juan Pedro Kusanovic Pivcevic; Chong Jai Kim; Tinnakorn chaiworapongsa; Deborah Hoppensteadt; Jawed Fareed; Nándor Gábor Than; Chia-Ling Nhan-Chang; Lami Yeo; P Pacora; Moshe Mazor; Sonia S Hassan; Pooja Mittal; Roberto Romero
Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2009;22(8):672-87.
2009: Boyangzi Li; Jiraporn Suwan; Jeffrey Martin; Fuming Zhang; Zhenqing Zhang; Debra Hoppensteadt; Melanie Clark; Jawed Fareed; Robert J Linhardt
Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.
Biochemical pharmacology 2009;78(3):292-300.
2009: Christian Viskov; E Bouley; P Hubert; Celine Martinez; F Herman; Walter Jeske; Debra Hoppensteadt; Jeanine M Walenga; Jawed Fareed
Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(4):395-401.
2009: Meganathan Kannan; Renu Saxena; Cafer Adiguzel; Jawed Fareed
An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
Seminars in thrombosis and hemostasis 2009;35(3):337-43.
2009: Giuseppe Cella; Fabrizio Vianello; Franco Cozzi; Helga Marotta; Francesco Tona; Graziella Saggiorato; Omer Iqbal; Jawed Fareed
Effect of bosentan on plasma markers of endothelial cell activity in patients with secondary pulmonary hypertension related to connective tissue diseases.
The Journal of rheumatology 2009;36(4):760-7.
2009: Cafer Adiguzel; Vinod Bansal; Evangelos Litinas; Josephine Cunanan; Omer Iqbal; Kelly Nelson; Meganathan Kannan; Debra Hoppensteadt; Jawed Fareed
Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(2):145-51.
2009: Cafer Adiguzel; Walter P Jeske; Debra Hoppensteadt; Jeanine M Walenga; Vinod Bansal; Jawed Fareed
Structural and functional characterization of low-molecular-weight heparins: impact on the development of guidelines for generic products.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(2):137-44.
2009: He Zhu; Debra Hoppensteadt; Cafer Adiguzel; Rodger L Bick; Jawed Fareed
Comparison of immunogenic potentials of bovine thrombin preparations.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(1):41-9.
2009: He Zhu; Debra Hoppensteadt; Rakesh Wahi; Josephine Cunanan; Cafer Adiguzel; Rodger L Bick; Jawed Fareed
Reduced immunogenic potential of membrane filtered bovine thrombin preparations for hemostatic application.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(1):32-40.
2009: John E Piletz; Angelos Halaris; Omer Iqbal; Debra Hoppensteadt; Jawed Fareed; He Zhu; James M Sinacore; C Lindsay DeVane
Pro-inflammatory biomakers in depression: treatment with venlafaxine.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4):313-23.
2008: OFFER EREZ; Roberto Romero; Debra Hoppensteadt; Nándor Gábor Than; Jawed Fareed; Shali Mazaki-Tovi; Jimmy Espinoza; Tinnakorn chaiworapongsa; Sung-Su Kim; Bo Hyun Yoon; Sonia S Hassan; Francesca Gotsch; Lara A Friel; Eduard Vaisbuch; Juan Pedro Kusanovic Pivcevic
Tissue factor and its natural inhibitor in pre-eclampsia and SGA.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2008;21(12):855-69.
2008: Lothar Heilmann; Martin Schorch; Thomas Hahn; Geza Adasz; Karin Schilberz; Cafer Adiguzel; Jawed Fareed
Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study.
Seminars in thrombosis and hemostasis 2008;34(8):794-802.
2008: OFFER EREZ; Jimmy Espinoza; Tinnakorn chaiworapongsa; Francesca Gotsch; Juan Pedro Kusanovic Pivcevic; Nándor Gábor Than; Shali Mazaki-Tovi; Eduard Vaisbuch; Zoltán Papp; Bo Hyun Yoon; Yu Mi Han; Debra Hoppensteadt; Jawed Fareed; Sonia S Hassan; Roberto Romero
A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2008;21(10):732-44.
2008: M Clark; Debra Hoppensteadt; Jeanine M Walenga; L Myers; J Cunanan; Walter P Jeske; C Adiguzel; Omer Iqbal; Jawed Fareed
Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
International angiology : a journal of the International Union of Angiology 2008;27(5):370-6.
2008: Jawed Fareed; Walter P Jeske; Daniel Fareed; Melaine Clark; Rakesh Wahi; Cafer Adiguzel; Debra Hoppensteadt
Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2008;14(4):385-92.
2008: Debra Hoppensteadt; Jawed Fareed; Allan L Klein; Susan E Jasper; Carolyn Apperson-Hansen; Elizabeth A Lieber; William E Katz; Joseph F Malouf; Marcus F Stoddard; Linda A Pape
Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.
The American journal of cardiology 2008;102(7):842-6.
2008: Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; OFFER EREZ; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic Pivcevic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn chaiworapongsa; Samuel Edwin; Beth L Pineles; Sonia S Hassan
Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2008;21(9):629-37.
2008: Debra A Hoppensteadt; Rakesh Wahi; Cafer Adiguzel; Omer Iqbal; Eduardo Ramacciotti; Rodger L Bick; Harry L Messmore; Vinod Bansal; Jawed Fareed
Contaminant in the recalled unfractionated heparin preparations: where is the problem?
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2008;14(3):261-6.
2008: Jawed Fareed; O Iqbal; J Cunanan; Muzaffer Demir; Rakesh Wahi; M Clarke; C Adiguzel; R Bick
Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
International angiology : a journal of the International Union of Angiology 2008;27(3):176-92.
2008: Abdel Terrab; Dan Pawlak; Pat Spaay; Debra Hoppensteadt; Jawed Fareed
Further removal of factor v related antigen from bovine thrombin by utilizing a membrane-filtration step.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2008;14(2):135-40.
2008: Walter P Jeske; Jeanine M Walenga; Debra A Hoppensteadt; Curtis Vandenberg; Aleah Brubaker; Cafer Adiguzel; Mamdouh Bakhos; Jawed Fareed
Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins.
Seminars in thrombosis and hemostasis 2008;34(1):74-85.
2008: Jawed Fareed; Debra A Hoppensteadt; Daniel Fareed; Muzaffer Demir; Rakesh Wahi; Melaine Clarke; Cafer Adiguzel; Rodger Bick
Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Seminars in thrombosis and hemostasis 2008;34(1):58-73.
2008: Debra A Hoppensteadt; Walter Jeske; Jeanine Walenga; Jawed Fareed
The future of anticoagulation.
Seminars in respiratory and critical care medicine 2008;29(1):90-9.
2008: William F Baker; Rodger L Bick; Jawed Fareed
Controversies and unresolved issues in antiphospholipid syndrome pathogenesis and management.
Hematology/oncology clinics of North America 2008;22(1):155-74, viii.
2008: Debra A Hoppensteadt; Nancy Fabbrini; Rodger L Bick; Harry L Messmore; Cafar Adiguzel; Jawed Fareed
Laboratory evaluation of the antiphospholipid syndrome.
Hematology/oncology clinics of North America 2008;22(1):19-32, v.
2008: OFFER EREZ; Roberto Romero; Debra Hoppensteadt; Jawed Fareed; Tinnakorn chaiworapongsa; Juan Pedro Kusanovic Pivcevic; Shali Mazaki-Tovi; Francesca Gotsch; Nándor Gábor Than; Eduard Vaisbuch; Chong Jai Kim; Jimmy Espinoza; Pooja Mittal; Neil Hamill; Chia-Ling Nhan-Chang; Moshe Mazor; Sonia S Hassan
Premature labor: a state of platelet activation?
Journal of perinatal medicine 2008;36(5):377-87.
2008: Jawed Fareed; Rodger L Bick; Gundu Rao; Samuel Z Goldhaber; Arthur Sasahara; Harry L Messmore; Debra A Happensteadt; Andrew Nicolaides
The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded products.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2008;14(1):5-7.
2007: Thyyar M Ravindranath; Masakatsu Goto; Omer Iqbal; Michelle Florian-Kujawski; Debra Hoppensteadt; Rashid Hammadeh; Mohammed M Sayeed; Jawed Fareed
Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007;13(4):362-8.
2007: OFFER EREZ; Debra Hoppensteadt; Roberto Romero; Jimmy Espinoza; Luis Goncalves; Jyh Kae Nien; Juan Pedro Kusanovic Pivcevic; Jawed Fareed; Francesca Gotsch; Beth L Pineles; Tinnakorn chaiworapongsa
Preeclampsia is associated with low concentrations of protein Z.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2007;20(9):661-7.
2007: Dominique Joyal; Ferdinand Leya; M Obada Al-Chekakie; Dinesh Arab; Robert S Dieter; Ali Morshedi-Meibodi; Bruce Lewis; Lowell Steen; Jawed Fareed; Debra Hoppenstead; Joseph G Akar
Presence of asymmetric dimethylarginine gradients across high-grade lesions in patients with coronary artery disease.
Coronary artery disease 2007;18(6):471-5.
2007: Sunil X Anand; Michael C Kim; Mazullah Kamran; Samin K Sharma; Annapoorna S Kini; Jawed Fareed; Debra A Hoppensteadt; Frank Carbon; Erdal Cavusoglu; David Varon; Juan F Viles-Gonzalez; Juan J Badimon; Jonathan D Marmur
Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin.
The American journal of cardiology 2007;100(3):417-24.
2007: Muzaffer Demir; Enver Duran; Omer Necmi Yigitbasi; Ozden Vural; Turhan Kurum; Mahmut Yuksel; Burhan Turgut; Jeanine M Walenga; Jawed Fareed
Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007;13(3):279-84.
2007: Juan Pedro Kusanovic Pivcevic; Jimmy Espinoza; Roberto Romero; Debra Hoppensteadt; Jyh Kae Nien; Chong Jai Kim; OFFER EREZ; Eleazar Soto; Jawed Fareed; Samuel Edwin; Tinnakorn Chaiwerapongsa; Nándor Gábor Than; Bo Hyun Yoon; Ricardo Gomez; Zoltán Papp; Sonia S Hassan
Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2007;20(6):453-63.
2007: Jawed Fareed; Rodger L Bick; Craig Kessler; Harry L Messmore; Gundu Rao; Arthur Sasahara; Sylvia Haas
Potential thrombogenic complications with the use of recombinant activated factor VII in combat trauma.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007;13(2):121-3.
2007: Jawed Fareed; Jeanine M Walenga
Why differentiate low molecular weight heparins for venous thromboembolism?
Thrombosis journal 2007;5():8.
2007: Qing Ma; Umberto Cornelli; Israel Hanin; Walter P Jeske; Robert J Linhardt; Jeanine M Walenga; Jawed Fareed; John Lee
Heparin oligosaccharides as potential therapeutic agents in senile dementia.
Current pharmaceutical design 2007;13(15):1607-16.
2007: Rashid M Rashid; John Lee; Jawed Fareed; M Rita I Young
In vitro heparan sulfate modulates the immune responses of normal and tumor-bearing mice.
Immunological investigations 2007;36(2):183-201.
2007: Jyothi Maddineni; Debra A Hoppensteadt; Umberto Cornelli; Marco Manoni; Jawed Fareed
Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2007;13(1):52-64.
2007: Qing Ma; Mahmut Tobu; Christopher Schultz; Walter P Jeske; Debra Hoppensteadt; Jeanine M Walenga; Umberto Cornelli; John Lee; Robert J Linhardt; Israel Hanin; Jawed Fareed
Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides.
Thrombosis research 2007;119(5):653-61.
2006: S Haas; H G Breyer; H P Bacher; Jawed Fareed; Frank Misselwitz; N Victor; J Weber
Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
International angiology : a journal of the International Union of Angiology 2006;25(4):335-42.
2006: Steven R Deitcher; Craig M Kessler; Geno Merli; James R Rigas; Roger M Lyons; Jawed Fareed
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(4):389-96.
2006: Jawed Fareed; Walter P Jeske; Debra A Hoppensteadt; Jeanine M Walenga
Update on the clinical applications of argatroban.
Future cardiology 2006;2(4):403-14.
2006: Jyothi Maddineni; Walter P Jeske; Francis Baltasar; Umberto Cornelli; Marco Manoni; Debra A Hoppensteadt; Jawed Fareed
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(3):311-7.
2006: Jyothi Maddineni; Jeanine M Walenga; Walter P Jeske; Debra A Hoppensteadt; Jawed Fareed; Rakesh Wahi; Rodger L Bick
Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(3):267-76.
2006: Soumaya El Rouby; Marc Cohen; Andrea Gonzales; Debra Hoppensteadt; Ted Lee; Marcia L Zucker; Khaula Khalid; Frank M LaDuca; Jawed Fareed
The use of a HEMOCHRON JR. HEMONOX point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures.
Journal of thrombosis and thrombolysis 2006;21(2):137-45.
2006: Wasim Haque; Jawed Fareed; William H Wehrmacher; Harry L Messmore
The classical vs nonclassical NSAIDs: can the reduction in pain overcome the thrombotic risk?
Comprehensive therapy 2006;32(4):261-6.
2006: Rashid M Rashid; John Lee; Jawed Fareed; M Rita I Young
In vivo heparan sulfate treatment alters the immune response of normal and LLC-bearing mice.
Immunopharmacology and immunotoxicology 2006;28(1):67-79.
2006: Omer Iqbal; Jawed Fareed
Clinical applications of bioinformatics, genomics, and pharmacogenomics.
Methods in molecular biology (Clifton, N.J.) 2006;316():159-77.
2006: Hani Basil Abdul-Jabar; George Geroulakos; Nicola Philpott; Jawed Fareed
Warfarin-induced skin necrosis: a case report.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(1):101-4.
2006: Sibel Guldiken; Burhan Turgut; Muzaffer Demir; Ender Arikan; Mujdat Kara; Ozden Vural; Armagan Tugrul; Jawed Fareed
The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(1):55-60.
2006: Harry L Messmore; Jawed Fareed; Rodger L Bick
Pitfalls in warfarin therapy.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2006;12(1):1-2.
2005: Sylvia Haas; Helmut Wolf; Ajay K Kakkar; Jawed Fareed; Albrecht Encke
Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
Thrombosis and haemostasis 2005;94(4):814-9.
2005: Harry L Messmore; Jawed Fareed; Jeanine M Walenga; Rodger L Bick
Argatroban and lepirudin: clinical trials to clinical practice.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2005;11(4):367-9.
2005: Jawed Fareed; Omer Iqbal; Helena Nader; Shaker A Mousa; Rakesh Wahi; Erwin Coyne; Rodger L Bick
Generic low molecular weight heparins: a significant dilemma.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2005;11(4):363-6.
2005: Meganathan Kannan; Sarfraz Ahmad; Firdos Ahmad; Shailaja Kale; Debra A Hoppensteadt; Jawed Fareed; Renu Saxena
Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(7):487-90.
2005: Jeanine M Walenga; Walter P Jeske; Jawed Fareed
Short- and long-acting synthetic pentasaccharides as antithrombotic agents.
Expert opinion on investigational drugs 2005;14(7):847-58.
2005: Jawed Fareed; Wendy Leong; Debra A Hoppensteadt; Walter P Jeske; Jeanine M Walenga; Rodger L Bick
Development of generic low molecular weight heparins: a perspective.
Hematology/oncology clinics of North America 2005;19(1):53-68, v-vi.
2005: Rodger L Bick; Eugene P Frenkel; Jeanine M Walenga; Jawed Fareed; Debra A Hoppensteadt
Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.
Hematology/oncology clinics of North America 2005;19(1):1-51, v.
2005: Jawed Fareed
New development in anticoagulant and antithrombotic therapy: are we on the right track?
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():140-1.
2005: Bettina Kemkes-Matthes; Jeanine M Walenga; Job Harenberg; Jawed Fareed
Argatroban treatment for patients with intolerance to heparin and hirudin.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2005;11(1):99-103.
2005: Mahmut Tobu; Qing Ma; Omer Iqbal; Christopher Schultz; Walter P Jeske; Debra A Hoppensteadt; Jawed Fareed
Comparative tissue factor pathway inhibitor release potential of heparins.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2005;11(1):37-47.
2005: Omer Iqbal; Mahmut Tobu; Salim Aziz; M Gerdisch; M Da Valle; Muzaffer Demir; Debra A Hoppensteadt; Sarfraz Ahmad; Jeanine M Walenga; Jawed Fareed
Successful use of recombinant hirudin and its monitoring by ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization.
Journal of cardiac surgery 2005;20(1):42-51.
2004: Michelle Florian-Kujawski; Debra Hoppensteadt; Jyothi Maddineni; H Ziegler; Jawed Fareed
Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins. Pharmacologic implications.
International angiology : a journal of the International Union of Angiology 2004;23(4):346-54.
2004: Jawed Fareed; Wendy L Leong; Debra A Hoppensteadt; Walter P Jeske; Jeanine M Walenga; Rakesh Wahi; Rodger L Bick
Generic low-molecular-weight heparins: some practical considerations.
Seminars in thrombosis and hemostasis 2004;30(6):703-13.
2004: Qing Ma; Jawed Fareed
Idraparinux sodium. Sanofi-Aventis.
IDrugs : the investigational drugs journal 2004;7(11):1028-34.
2004: Thyyar M Ravindranath; Masakatsu Goto; Muzaffer Demir; Mahmut Tobu; M Florian Kujawski; Debra Hoppensteadt; Victoria Samonte; Omer Iqbal; Mohammed M Sayeed; Jawed Fareed
Tissue factor pathway inhibitor and thrombin activatable fibrinolytic inhibitor plasma levels following burn and septic injuries in rats.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(4):379-85.
2004: Daniel Fareed; Omer Iqbal; Mahmut Tobu; Debra A Hoppensteadt; Jawed Fareed
Blood levels of nitric oxide, C-reactive protein, and tumor necrosis factor-alpha are upregulated in patients with malignancy-associated hypercoagulable state: pathophysiologic implications.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(4):357-64.
2004: Mahmut Tobu; Omer Iqbal; Debra Hoppensteadt; Brian Neville; Harry L Messmore; Jawed Fareed
Anti-Xa and anti-IIa drugs alter international normalized ratio measurements: potential problems in the monitoring of oral anticoagulants.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(4):301-9.
2004: Jawed Fareed; Rodger Bick
Differentiation of low-molecular-weight heparins: practical implications.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(4):299-300.
2004: Michelle Florian-Kujawski; W Hussain; B Chyna; Steven Kahn; Debra Hoppensteadt; Ferdinand Leya; Jawed Fareed
Biomarker profiling of plasma from acute coronary syndrome patients. Application of ProteinChip Array analysis.
International angiology : a journal of the International Union of Angiology 2004;23(3):246-54.
2004: Fuming Zhang; Yi Wu; Qing Ma; Debra Hoppensteadt; Jawed Fareed; Robert J Linhardt
Studies on the effect of calcium in interactions between heparin and heparin cofactor II using surface plasmon resonance.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(3):249-57.
2004: Mahmut Tobu; Omer Iqbal; Daniel Fareed; Maninder Chatha; Debra Hoppensteadt; Vinod Bansal; Jawed Fareed
Erythropoietin-induced thrombosis as a result of increased inflammation and thrombin activatable fibrinolytic inhibitor.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(3):225-32.
2004: Jawed Fareed; Walter P Jeske
Small-molecule direct antithrombins: argatroban.
Best practice & research. Clinical haematology 2004;17(1):127-38.
2004: Sarfraz Ahmad; Brian Untch; Sylvia Haas; Debra A Hoppensteadt; Frank Misselwitz; Harry L Messmore; Jeanine M Walenga; Jawed Fareed
Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesis.
Molecular and cellular biochemistry 2004;258(1-2):163-70.
2004: Debra A Hoppensteadt; Jawed Fareed; Rodger L Bick
Epilogue. Expanded role of low-molecular-weight heparins in hematology and oncology.
Seminars in thrombosis and hemostasis 2004;30 Suppl 1():105-8.
2004: Jawed Fareed; Qing Ma; Michelle Florian; Jyothi Maddineni; Omer Iqbal; Debra A Hoppensteadt; Rodger L Bick
Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosis.
Seminars in thrombosis and hemostasis 2004;30 Suppl 1():89-104.
2004: Harry L Messmore; William H Wehrmacher; Erwin Coyne; Jawed Fareed
Heparin to pentasaccharide and beyond: the end is not in sight.
Seminars in thrombosis and hemostasis 2004;30 Suppl 1():81-8.
2004: Debra A Hoppensteadt; Louise Willows; Helen Leitz; Andrew Nicolaides; Jawed Fareed
Laboratory analysis of blood samples from patients treated with tinzaparin.
Seminars in thrombosis and hemostasis 2004;30 Suppl 1():49-55.
2004: Walter P Jeske; Jawed Fareed
Pharmacodynamic considerations in the selection of dosage of tinzaparin for various indications: experimental studies in primates.
Seminars in thrombosis and hemostasis 2004;30 Suppl 1():41-7.
2004: Harry L Messmore; Erwin Coyne; William H Wehrmacher; A M Demir; Jawed Fareed
Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: a literature review.
Current pharmaceutical design 2004;10(9):1001-10.
2004: Jawed Fareed; Debra Hoppensteadt; Christopher Schultz; Qing Ma; Michelle Florian Kujawski; Brian Neville; Harry L Messmore
Biochemical and pharmacologic heterogeneity in low molecular weight heparins. Impact on the therapeutic profile.
Current pharmaceutical design 2004;10(9):983-99.
2004: Cetin Gül; Turhan Kürüm; Muzaffer Demir; Gultac Ozbay; Ozden Vural; Omer Iqbal; Jawed Fareed
Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(1):77-9.
2004: Meganathan Kannan; Rafeeq Ahmed; Shailaja Kale; Sarfraz Ahmad; Jawed Fareed; Renu Saxena
Laboratory diagnosis of heparin-induced thrombocytopenia in Asian Indians as investigated with functional and immunologic methods.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(1):51-4.
2004: Jyothi Maddineni; Qing Ma; Debra A Hoppensteadt; Muzaffer Demir; Marco Manoni; Umberto Cornelli; Jawed Fareed
Molecular and pharmacologic profile of tinzaparin and a comparable low-molecular-weight bacterial sulfaminoheparosan.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2004;10(1):27-37.
2004: Walter P Jeske; Omer Iqbal; Jawed Fareed; Brigitte Kaiser
A survey of venous thrombosis models.
Methods in molecular medicine 2004;93():221-37.
2004: Shaker A Mousa; Jawed Fareed; Omer Iqbal; Brigitte Kaiser
Tissue factor pathway inhibitor in thrombosis and beyond.
Methods in molecular medicine 2004;93():133-55.
2004: Jeanine M Walenga; Walter P Jeske; Debra Hoppensteadt; Jawed Fareed
Factor Xa inhibitors.
Methods in molecular medicine 2004;93():95-117.
2003: Rolandas Gerbutavicius; Omer Iqbal; Harry L Messmore; William H Wehrmacher; Debra A Hoppensteadt; Rima Gerbutaviciene; Rasa Griniute; Jawed Fareed
Differential effects of DX-9065a, argatroban, and synthetic pentasaccharide on tissue thromboplastin inhibition test and dilute Russell's viper venom test.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2003;9(4):317-23.
2003: Mahmut Tobu; Omer Iqbal; Harry L Messmore; Qing Ma; Debra A Hoppensteadt; Jawed Fareed
Influence of different anticoagulant agents on fibrinopeptide a generation.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2003;9(4):273-92.
2003: Thomas W Stief; Jawed Fareed
Point of care: diagnostics in hemostasis--the wrong direction?
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2003;9(3):191-5.
2003: Sarfraz Ahmad; H Peter Bacher; Michael R Lassen; Debra A Hoppensteadt; Helen Leitz; Frank Misselwitz; Jeanine M Walenga; Jawed Fareed
Investigations of the immunoglobulin subtype transformation of anti-heparin-platelet factor 4 antibodies during treatment with a low-molecular-weight heparin (clivarin) in orthopedic patients.
Archives of pathology & laboratory medicine 2003;127(5):584-8.
2003: Jawed Fareed; Debra A Hoppensteadt; Rodger L Bick
Management of thrombotic and cardiovascular disorders in the new millenium.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2003;9(2):101-8.
2003: Omer Iqbal; Bo Eklof; Mahmut Tobu; Jawed Fareed
Air travel-associated venous thromboembolism.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2003;12(2):73-80.
2003: Jeanine M Walenga; Walter P Jeske; Debra Hoppensteadt; Jawed Fareed
Factor Xa inhibitors: today and beyond.
Current opinion in investigational drugs (London, England : 2000) 2003;4(3):272-81.
2003: Jonathan D Marmur; Sunil X Anand; Ramanjit S Bagga; Jawed Fareed; Chi-Miau Pan; Samin K Sharma; Merwin F Richard
The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration.
Journal of the American College of Cardiology 2003;41(3):394-402.
2003: Debra Hoppensteadt; Jeanine M Walenga; Jawed Fareed; Rodger L Bick
Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiation.
Hematology/oncology clinics of North America 2003;17(1):313-41.
2003: Qing Ma; Christopher Schultz; Brian Neville; Walter P Jeske; Debra Hoppensteadt; Umberto Cornelli; John Lee; Stanley Lorens; Israel Hanin; Jawed Fareed
Pharmacodynamics and pharmacokinetics of C3, a heparin-derived oligosaccharide mixture, in non-human primates.
Thrombosis research 2003;112(4):249-55.
2003: Jawed Fareed; Debra Hoppensteadt; Jeanine M Walenga; Omer Iqbal; Qing Ma; Walter P Jeske; Taqdees Sheikh
Pharmacodynamic and pharmacokinetic properties of enoxaparin : implications for clinical practice.
Clinical pharmacokinetics 2003;42(12):1043-57.
2003: Mahmut Tobu; Omer Iqbal; Qing Ma; Christopher Schultz; Walter P Jeske; Debra Hoppensteadt; Bruce Lewis; Daniel Fareed; Jawed Fareed
Global anticoagulant effects of a synthetic anti-factor Xa inhibitor (DX-9065a): implications for interventional use.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2003;9(1):1-17.
2002: Sarfraz Ahmad; Sylvia Haas; Debra A Hoppensteadt; Helen Lietz; Ulrike Reid; Norbert Bender; Harry L Messmore; Frank Misselwitz; Peter Bacher; Bhavna S Gaikwad; Walter P Jeske; Jeanine M Walenga; Jawed Fareed
Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.
Thrombosis research 2002;108(1):49-55.
2002: Mahmut Tobu; Omer Iqbal; Debra A Hoppensteadt; Christopher Shultz; Walter P Jeske; Jawed Fareed
Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory tests.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2002;8(4):325-36.
2002: Guangli Yu; Nur Sibel Gunay; Robert J Linhardt; Toshihiko Toida; Jawed Fareed; Debra A Hoppensteadt; Hazar Shadid; Vito Ferro; Caiping Li; Kym Fewings; Maria C Palermo; Denis Podger
Preparation and anticoagulant activity of the phosphosulfomannan PI-88.
European journal of medicinal chemistry 2002;37(10):783-91.
2002: Magdalene M George; David H Van Thiel; George Tarasuk; Gregorio Chejfec; Kenneth D McClatchey; Raza S. Hamdani; Jawed Fareed
Hemostatic modulation with the liver dialysis device in humans with advanced liver disease.
Hepato-gastroenterology 2002;49(47):1333-9.
2002: Omer Iqbal; Sarfraz Ahmad; Bruce E Lewis; Jeanine M Walenga; Yadira Rangel; Jawed Fareed
Monitoring of argatroban in ARG310 study: potential recommendations for its use in interventional cardiology.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2002;8(3):217-24.
2002: Mark Walzer; Stanley Lorens; Matthew J Hejna; Jawed Fareed; Israel Hanin; Umberto Cornelli; John Lee
Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathology.
European journal of pharmacology 2002;445(3):211-20.
2002: Shaker A Mousa; Omar Iqbal; Jawed Fareed
Antithrombotics and thrombolytics in stroke.
Current opinion in investigational drugs (London, England : 2000) 2002;3(6):878-85.
2002: Omer Iqbal; Harry L Messmore; Jawed Fareed; Sarfraz Ahmad; Debra Hoppensteadt; Shadid Hazar; Mahmut Tobu; Salim Aziz; William H Wehrmacher
Antithrombotic agents in the treatment of severe sepsis.
Expert opinion on emerging drugs 2002;7(1):111-39.
2002: Brian Untch; Sarfraz Ahmad; Harry L Messmore; Christopher L Schultz; Qing Ma; Debra A Hoppensteadt; Jeanine M Walenga; Jawed Fareed
Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies.
Thrombosis research 2002;106(2):149-56.
2002: Rolandas Gerbutavicius; Jawed Fareed; Harry L Messmore; Omer Iqbal; Debra A Hoppensteadt; William H Wehrmacher; Muzaffer Demir; Peter Piccolo; Sarfraz Ahmad; Qing Ma; Rasa Griniute
Reference intervals of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisited.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2002;8(2):115-24.
2002: Vijay V Kakkar; Debra A Hoppenstead; Jawed Fareed; Zbigniew Kadziola; Mike Scully; Roumen Nakov; Hans Klaus Breddin
Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis.
Blood 2002;99(6):1965-70.
2002: Qing Ma; Bertalan Dudas; Matthew J Hejna; Umberto Cornelli; John Lee; Stanley Lorens; Ronald Mervis; Israel Hanin; Jawed Fareed
The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3.
Thrombosis research 2002;105(5):447-53.
2002: Jeanine M Walenga; Walter P Jeske; M Michel Samama; F Xavier Frapaise; Rodger L Bick; Jawed Fareed
Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent.
Expert opinion on investigational drugs 2002;11(3):397-407.
2002: Qing Ma; Bertalan Dudas; Asif Daud; Omer Iqbal; Debra Hoppensteadt; Walter P Jeske; Umberto Cornelli; John Lee; Stanley Lorens; Ronald Mervis; Israel Hanin; Ishan Capila; Robert J Linhardt; Jawed Fareed
Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3.
Thrombosis research 2002;105(4):303-9.
2002: Brian Untch; Sarfraz Ahmad; Walter P Jeske; Harry L Messmore; Debra A Hoppensteadt; Jeanine M Walenga; Helen Lietz; Jawed Fareed
Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
Thrombosis research 2002;105(2):117-23.
2002: Jawed Fareed; Debra Hoppensteadt; Omer Iqbal; Mahmut Tobu; Bruce E Lewis
Practical issues in the development of argatroban: a perspective.
Pathophysiology of haemostasis and thrombosis 2002;32 Suppl 3():56-65.
2002: Rolandas Gerbutavicius; Jawed Fareed; Harry L Messmore; Omer Iqbal; William H Wehrmacher; Debra A Hoppensteadt; Muzaffer Demir; Peter Piccolo; Sarfraz Ahmad; Qing Ma; Rasa Griniute
Reference ranges of the dilute tissue thromboplastin inhibition and dilute Russell's viper venom tests revisited.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2002;8(1):51-9.
2001: Eric D Grassman; Ferdinand Leya; Jawed Fareed; Bruce E Lewis; Peter Bacher; Henry S Loeb; John F Moran
A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty.
The Journal of invasive cardiology 2001;13(11):723-8.
2001: Jawed Fareed; T Shaikh; Debra A Hoppensteadt
Antithrombin and anti-Xa agents in the control of thrombogenesis.
Die Pharmazie 2001;56 Suppl 1():S12-21.
2001: Debra A Hoppensteadt; Jawed Fareed; P Raake; W Raake
Endogenous release of tissue factor pathway inhibitor by topical application of an ointment containing mucopolysaccharide polysulfate to nonhuman primates.
Thrombosis research 2001;103(2):157-63.
2001: Sarfraz Ahmad; Walter P Jeske; Qing Ma; Jeanine M Walenga; Jawed Fareed
Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonist.
Thrombosis research 2001;102(2):143-51.
2001: Bruce E Lewis; Diane E Wallis; Scott Darrell Berkowitz; William H Matthai; Jawed Fareed; Jeanine M Walenga; John R Bartholomew; R Sham; R G Lerner; Z R Zeigler; P K Rustagi; Ik-Kyung Jang; S D Rifkin; J Moran; Marcie J Hursting; John G Kelton
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
Circulation 2001;103(14):1838-43.
2001: Omer Iqbal; Salim Aziz; Debra A Hoppensteadt; Sarfraz Ahmad; J M Walenga; Mamdouh Bakhos; Jawed Fareed
Emerging anticoagulant and thrombolytic drugs.
Expert opinion on emerging drugs 2001;6(1):111-35.
2001: David H Van Thiel; Magdalene George; Jawed Fareed
Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease.
Thrombosis and haemostasis 2001;85(4):667-70.
2001: Peter Piccolo; Omer Iqbal; Muzaffer Demir; Qing Ma; Rolandas Gerbutavicius; Jawed Fareed
Global anticoagulant effects of a novel sulfated pentomanan oligosaccharide mixture.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(2):149-52.
2001: Muzaffer Demir; Omer Iqbal; Debra A Hoppensteadt; Peter Piccolo; Sarfraz Ahmad; C L Schultz; R J Linhardt; Jawed Fareed
Anticoagulant and antiprotease profiles of a novel natural heparinomimetic mannopentaose phosphate sulfate (PI-88).
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(2):131-40.
2001: Asif Daud; A Ahsan; Omer Iqbal; Jeanine M Walenga; P J Silver; Sarfraz Ahmad; Jawed Fareed
Synthetic heparin pentasaccharide depolymerization by heparinase I: molecular and biological implications.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(1):58-64.
2001: Muzaffer Demir; Omer Iqbal; Carl P Dietrich; Debra A Hoppensteadt; Sarfraz Ahmad; Asif Daud; Jawed Fareed
Anticoagulant and antiprotease effects of a novel heparinlike compound from shrimp (Penaeus brasiliensis) and its neutralization by heparinase I.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(1):44-52.
2001: Muzaffer Demir; Omer Iqbal; Brian Untch; Debra A Hoppensteadt; B S Gaikwad; Jawed Fareed
Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(1):38-43.
2001: M K Orcullo Santillan; J Herring; Debra A Hoppensteadt; Walter P Jeske; JM Herbert; Jawed Fareed
The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(1):10-5.
2000: Guangli Yu; Laurie A LeBrun; Nur Sibel Gunay; D Hoppensteadt; J M Walenga; Jawed Fareed; Robert J Linhardt
Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site.
Thrombosis research 2000;100(6):549-56.
2000: Sarfraz Ahmad; Walter P Jeske; Jeanine M Walenga; A Aldabbagh; Omer Iqbal; Jawed Fareed
Human anti-heparin-platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primates.
Thrombosis research 2000;100(1):47-54.
2000: Rolandas Gerbutavicius; Omer Iqbal; Harry L Messmore; Debra A Hoppensteadt; Muzaffer Demir; E Khan; Peter Bacher; Jawed Fareed
Differential effects of unfractionated heparin and low-molecular-weight heparins on tissue thromboplastin inhibition test.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2000;6(4):190-6.
2000: A Ahsan; Walter P Jeske; H Wolf; Jawed Fareed
Isoamyl nitrite depolymerized heparin as a universal calibrator for heparins and low molecular weight heparins.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2000;6(3):169-74.
2000: Sarfraz Ahmad; L H Yang; A Ahsan; K Fu; Omer Iqbal; Debra A Hoppensteadt; Bruce E Lewis; Jeanine M Walenga; Jawed Fareed
Pharmacokinetics of argatroban in primates: evidence on endogenous uptake.
International angiology : a journal of the International Union of Angiology 2000;19(2):126-34.
2000: Brigitte Kaiser; M Paintz; O Scholz; S Kunitada; Jawed Fareed
A synthetic inhibitor of factor Xa, DX-9065a, reduces proliferation of vascular smooth muscle cells in vivo in rats.
Thrombosis research 2000;98(2):175-85.
2000: H M Amin; Sarfraz Ahmad; Jeanine M Walenga; Debra A Hoppensteadt; Helen Leitz; Jawed Fareed
Soluble P-selectin in human plasma: effect of anticoagulant matrix and its levels in patients with cardiovascular disorders.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2000;6(2):71-6.
2000: Jawed Fareed; Debra A Hoppensteadt; Rodger L Bick
An update on heparins at the beginning of the new millennium.
Seminars in thrombosis and hemostasis 2000;26 Suppl 1():5-21.
2000: Omer Iqbal; Harry L Messmore; Debra Hoppensteadt; Jawed Fareed; William H Wehrmacher
Thrombolytic drugs in acute myocardial infarction.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2000;6(1):1-13.
1999: Brigitte Kaiser; W Jeske; Jeanine M Walenga; Jawed Fareed
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10(8):495-501.
1999: Debra A Hoppensteadt; Walter P Jeske; Jeanine M Walenga; K Fu; LH Yang; T S Ing; JM Herbert; Jawed Fareed
Laboratory monitoring of pentasaccharide in a dog model of hemodialysis.
Thrombosis research 1999;96(2):115-24.
1999: Jawed Fareed; Bruce E Lewis; DD Callas; Debra A Hoppensteadt; Jeanine M Walenga; Rodger L Bick
Antithrombin agents: the new class of anticoagulant and antithrombotic drugs.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 1999;5 Suppl 1():S45-55.
1999: Jawed Fareed; Jeanine M Walenga; Debra A Hoppensteadt; Walter P Jeske; Sarfraz Ahmad; Helen Lietz; R McKenna; Harry L Messmore; Sylvia Haas
Soluble adhesion molecules in the HIT syndrome: pathophysiologic role and therapeutic modulation.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 1999;5 Suppl 1():S38-44.
1999: Sarfraz Ahmad; Jeanine M Walenga; Walter P Jeske; Giuseppe Cella; Jawed Fareed
Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 1999;5 Suppl 1():S32-7.
1999: Sarfraz Ahmad; Walter P Jeske; Jeanine M Walenga; Debra A Hoppensteadt; JJ Wood; J M Herbert; Harry L Messmore; Jawed Fareed
Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 1999;5(4):259-66.
1999: Sarfraz Ahmad; A Ahsan; M George; Omer Iqbal; Walter P Jeske; R McKenna; Bruce E Lewis; Jeanine M Walenga; Jawed Fareed
Simultaneous monitoring of argatroban and its major metabolite using an HPLC method: potential clinical applications.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 1999;5(4):252-8.
1999: Sarfraz Ahmad; Omer Iqbal; A Ahsan; Debra A Hoppensteadt; Bruce E Lewis; Jeanine M Walenga; Jawed Fareed
Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using high performance liquid chromatography and functional methods.
International angiology : a journal of the International Union of Angiology 1999;18(3):198-205.
1999: Walter P Jeske; Jeanine M Walenga; B E Lewis; Jawed Fareed
Pharmacology of argatroban.
Expert opinion on investigational drugs 1999;8(5):625-54.
1999: Jawed Fareed; Debra A Hoppensteadt; Ferdinand Leya; B Lewis; DD Callas; H Wolf; Rodger L Bick
Thrombogenesis in myocardial infarction and related syndromes: the role of molecular markers in diagnosis and management.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 1999;5(2):78-91.
1999: Walter P Jeske; H Wolf; A Ahsan; Jawed Fareed
Pharmacologic profile of certoparin.
Expert opinion on investigational drugs 1999;8(3):315-27.
1999: Jawed Fareed; K Fu; L H Yang; Debra A Hoppensteadt
Pharmacokinetics of low molecular weight heparins in animal models.
Seminars in thrombosis and hemostasis 1999;25 Suppl 3():51-5.
1999: B Kaiser; Carl M Kirchmaier; Hans Klaus Breddin; K Fu; Jawed Fareed
Preclinical biochemistry and pharmacology of low molecular weight heparins in vivo--studies of venous and arterial thrombosis.
Seminars in thrombosis and hemostasis 1999;25 Suppl 3():35-42.
1999: Walter P Jeske; Jawed Fareed
In vitro studies on the biochemistry and pharmacology of low molecular weight heparins.
Seminars in thrombosis and hemostasis 1999;25 Suppl 3():27-33.
1999: Jawed Fareed; Debra A Hoppensteadt; Walter P Jeske; Sarfraz Ahmad; Rodger L Bick
Acquired defects of fibrinolysis associated with thrombosis.
Seminars in thrombosis and hemostasis 1999;25(4):367-74.
1999: Jeanine M Walenga; Walter P Jeske; Diane E Wallis; Mamdouh Bakhos; Bruce E Lewis; Ferdinand Leya; Jawed Fareed
Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT.
Seminars in thrombosis and hemostasis 1999;25 Suppl 1():77-81.
1999: Keith F Izban; Helen Lietz; Debra A Hoppensteadt; Walter P Jeske; Jawed Fareed; Mamdouh Bakhos; Jeanine M Walenga
Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
Seminars in thrombosis and hemostasis 1999;25 Suppl 1():51-6.
1999: Jawed Fareed; Jeanine M Walenga; Debra A Hoppensteadt; Walter P Jeske; Helen Lietz; Sarfraz Ahmad; DD Callas; Harry L Messmore; Sylvia Haas
Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation.
Seminars in thrombosis and hemostasis 1999;25 Suppl 1():37-42.
1999: Jawed Fareed; DD Callas; Debra A Hoppensteadt; Bruce E Lewis; Rodger L Bick; Jeanine M Walenga
Antithrombin agents as anticoagulants and antithrombotics: implications in drug development.
Seminars in hematology 1999;36(1 Suppl 1):42-56.
1998: S J Blair; M Chinthagada; D Hoppenstehdt; R Kijowski; Jawed Fareed
Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy.
Acta orthopaedica Belgica 1998;64(4):448-51.
1998: LH Yang; Debra Hoppensteadt; Jawed Fareed
Modulation of vasoconstriction by clopidogrel and ticlopidine.
Thrombosis research 1998;92(2):83-9.
1998: Jawed Fareed; Walter P Jeske; Debra Hoppensteadt; R Clarizio; Jeanine M Walenga
Low-molecular-weight heparins: pharmacologic profile and product differentiation.
The American journal of cardiology 1998;82(5B):3L-10L.
1998: Brigitte Kaiser; E Glusa; D A Hoppensteadt; Hans Klaus Breddin; J Amiral; Jawed Fareed
A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(6):517-23.
1998: Jawed Fareed; Debra Hoppensteadt; Walter P Jeske; R Clarizio; Jeanine M Walenga
Low molecular weight heparins: are they different?
The Canadian journal of cardiology 1998;14 Suppl E():28E-34E.
1998: Jawed Fareed; Debra A Hoppensteadt; Ferdinand Leya; Omer Iqbal; H Wolf; R Bick
Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes.
Clinical chemistry 1998;44(8 Pt 2):1845-53.
1998: B Kaiser; DD Callas; Jeanine M Walenga; Jawed Fareed
Synthetic and recombinant antithrombin drugs.
Expert opinion on investigational drugs 1998;7(6):963-85.
1998: Erwin Coyne; Harry L Messmore; Jeanine M Walenga; Jawed Fareed; William H Wehrmacher
Ethylenediaminetetraacetic acid (EDTA) in heparin.
Thrombosis research 1998;90(5):245-6.
1998: Jawed Fareed; DD Callas; Debra A Hoppensteadt; Jeanine M Walenga; Rodger L Bick
Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development.
The Medical clinics of North America 1998;82(3):569-86.
1998: Bruce E Lewis; Yadira Rangel; Jawed Fareed
The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.
Angiology 1998;49(1):61-7.
1997: Debra A Hoppensteadt; Walter P Jeske; Jeanine M Walenga; K Fu; LH Yang; T Ing; JM Herbert; Jawed Fareed
Efficacy of pentasaccharide in a dog model of hemodialysis.
Thrombosis research 1997;88(2):159-70.
1997: Brigitte Kaiser; W Jeske; D H Hoppensteadt; Jeanine M Walenga; W Drohan; Jawed Fareed
In vitro studies on the effect of activated protein C on platelet activation and thrombin generation.
Thrombosis research 1997;87(2):197-204.
1997: LH Yang; Jawed Fareed
Vasomodulatory action of clopidogrel and ticlopidine.
Thrombosis research 1997;86(6):479-91.
1997: Jawed Fareed; Debra Hoppensteadt; Walter P Jeske; R Clarizio; Jeanine M Walenga
Low molecular weight heparins: a developmental perspective.
Expert opinion on investigational drugs 1997;6(6):705-33.
1997: K Fu; R Izquierdo; Darl K Vandevender; R L Warpeha; H Wolf; Jawed Fareed
Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model.
Thrombosis research 1997;86(5):355-61.
1997: Jeanine M Walenga; Walter P Jeske; L Bara; M M Samama; Jawed Fareed
Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide.
Thrombosis research 1997;86(1):1-36.
1997: Walter P Jeske; Jawed Fareed; V Eschenfelder; Omer Iqbal; Debra Hoppensteadt; A Ahsan
Biochemical and pharmacologic characteristics of Reviparin, a low-molecular-mass heparin.
Seminars in thrombosis and hemostasis 1997;23(2):119-28.
1996: LH Yang; Debra A Hoppensteadt; Omer Iqbal; Jawed Fareed
Defibrotide mediated inhibition of serotonin, endothelin-I, thromboxane, and serum induced contraction of canine femoral and pulmonary arterial rings.
Thrombosis research 1996;84(3):167-77.
1996: DD Callas; Jawed Fareed
Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method.
Thrombosis research 1996;83(6):463-8.
1996: DD Callas; Jawed Fareed
Comparative studies on the antithrombin potency of various thrombin inhibitors, as determined by using an amidolytic method.
Thrombosis research 1996;83(1):97-102.
1996: J M Hayes; Walter P Jeske; DD Callas; Omer Iqbal; Jawed Fareed
Comparative intravenous antithrombotic actions of heparin and site directed thrombin inhibitors in a jugular vein clamping model.
Thrombosis research 1996;82(2):187-91.
1996: LH Yang; DD Callas; JM Herbert; Jawed Fareed
Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT2 antagonist (SR46349).
Thrombosis research 1996;81(5):555-67.
1996: Debra A Hoppensteadt; Walter P Jeske; Jawed Fareed; Andrew N Nicolaides
Physical and pharmacologic manipulation of the vascular system as measured by the release of TFPI and other mediators of antithrombotic actions.
International angiology : a journal of the International Union of Angiology 1996;15(1):39-46.
1996: Jawed Fareed; Debra A Hoppensteadt
Pharmacology of the low-molecular-weight heparins.
Seminars in thrombosis and hemostasis 1996;22 Suppl 2():13-8.
1996: Jawed Fareed; Walter P Jeske; V Eschenfelder; Omer Iqbal; Debra Hoppensteadt; A Ahsan
Preclinical studies on a low molecular weight heparin.
Thrombosis research 1996;81(2 Suppl):S1-27.
1996: Jawed Fareed; Walter P Jeske; Debra Hoppensteadt; R Clarizio; Jeanine M Walenga
Are the available low-molecular-weight heparin preparations the same?
Seminars in thrombosis and hemostasis 1996;22 Suppl 1():77-91.
1996: Jawed Fareed
Current trends in antithrombotic drug and device development.
Seminars in thrombosis and hemostasis 1996;22 Suppl 1():3-8.
1996: Walter P Jeske; Debra Hoppensteadt; DD Callas; M J Koza; Jawed Fareed
Pharmacological profiling of recombinant tissue factor pathway inhibitor.
Seminars in thrombosis and hemostasis 1996;22(2):213-9.
1995: Debra A Hoppensteadt; A Fasanella; Jawed Fareed
Effect of protamine on heparin releasable TFPI antigen levels in normal volunteers.
Thrombosis research 1995;79(3):325-30.
1995: DD Callas; Jawed Fareed
Comparative pharmacology of site directed antithrombin agents. Implication in drug development.
Thrombosis and haemostasis 1995;74(1):473-81.
1995: J R Chamberlin; B Lewis; Ferdinand Leya; Diane E Wallis; Harry L Messmore; Debra Hoppensteadt; Jeanine M Walenga; S Moran; Jawed Fareed; Thomas McKiernan
Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
The Canadian journal of cardiology 1995;11(6):511-4.
1995: K Fu; R Izquierdo; Jeanine M Walenga; Jawed Fareed
Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model.
Thrombosis research 1995;78(5):421-8.
1995: Walter P Jeske; Debra Hoppensteadt; Jawed Fareed; E Bermes
Measurement of functional and immunologic levels of tissue factor pathway inhibitor. Some methodologic considerations.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6 Suppl 1():S73-80.
1995: Debra A Hoppensteadt; Walter P Jeske; Jawed Fareed; E W Bermes
The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6 Suppl 1():S57-64.
1995: Jawed Fareed; DD Callas; Debra Hoppensteadt; E W Bermes
Tissue factor antigen levels in various biological fluids.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6 Suppl 1():S32-6.
1995: A Ahsan; Walter P Jeske; Debra Hoppensteadt; J C Lormeau; H Wolf; Jawed Fareed
Molecular profiling and weight determination of heparins and depolymerized heparins.
Journal of pharmaceutical sciences 1995;84(6):724-7.
1995: DD Callas; Jawed Fareed
Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy.
Thrombosis research 1995;78(5):457-60.
1995: L Iyer; Jawed Fareed
Determination of specific activity of recombinant hirudin using a thrombin titration method.
Thrombosis research 1995;78(3):259-63.
1995: Walter P Jeske; Debra Hoppensteadt; R Klauser; A Kammereit; P Eckenberger; S Haas; P Wyld; Jawed Fareed
Effect of repeated Aprosulate and Enoxaparin administration on tissue factor pathway inhibitor antigen levels.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(2):119-24.
1995: Jawed Fareed; R L Bick; Debra A Hoppensteadt; Jeanine M Walenga; H L Messmore; E W Bermes
Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disorders.
Clinics in laboratory medicine 1995;15(1):39-61.
1995: M J Koza; T C Shankey; Jeanine M Walenga; R Moncada; Jawed Fareed; R Pifarre
Flow cytometric evaluation of platelet activation by ionic or nonionic contrast media and modulation by heparin and recombinant hirudin.
Investigative radiology 1995;30(2):90-7.
1995: Debra A Hoppensteadt; Jeanine M Walenga; A Fasanella; Walter P Jeske; Jawed Fareed
TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin.
Thrombosis research 1995;77(2):175-85.
1995: Omer Iqbal; Walter P Jeske; Debra Hoppensteadt; M Koza; Jeanine M Walenga; Jawed Fareed; R Moncada
Procoagulant and anticoagulant effects of intravascular contrast media as assessed by thromboelastography.
Seminars in thrombosis and hemostasis 1995;21 Suppl 4():86-90.
1995: Omer Iqbal; Walter P Jeske; Debra Hoppensteadt; Jeanine M Walenga; Jawed Fareed
The approach of thromboelastography in the monitoring of new synthetic antithrombotic agents, GL-522 and GL-2021.
Seminars in thrombosis and hemostasis 1995;21 Suppl 4():72-5.
1995: B Lojewski; P Bacher; Omer Iqbal; Jeanine M Walenga; Debra Hoppensteadt; Ferdinand Leya; Jawed Fareed
Evaluation of hemostatic and fibrinolytic alterations associated with daily administration of low-molecular-weight heparin for a 12-week period.
Seminars in thrombosis and hemostasis 1995;21(2):228-39.
1995: Jawed Fareed; Walter P Jeske; V Eschenfelder; Omer Iqbal; Debra Hoppensteadt; A Ahsan
Pharmacologic validation of the clinical effects of an optimized low-molecular-weight heparin-reviparin.
Seminars in thrombosis and hemostasis 1995;21(2):212-27.
1995: Walter P Jeske; J C Lormeau; DD Callas; Omer Iqbal; Debra Hoppensteadt; Jawed Fareed
Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins.
Seminars in thrombosis and hemostasis 1995;21(2):193-200.
1995: L Iyer; M Adam; J Amiral; Jawed Fareed; E Bermes
Development and validation of two enzyme-linked immunosorbent assay (ELISA) methods for recombinant hirudin.
Seminars in thrombosis and hemostasis 1995;21(2):184-92.
1995: DD Callas; Debra Hoppensteadt; Jawed Fareed
Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin.
Seminars in thrombosis and hemostasis 1995;21(2):177-83.
1995: DD Callas; P Bacher; Jawed Fareed
Studies on the thrombogenic effects of recombinant tissue factor. In vivo versus ex vivo findings.
Seminars in thrombosis and hemostasis 1995;21(2):166-76.
1995: Jawed Fareed; Debra Hoppensteadt; L Iyer; M Koza; Jeanine M Walenga; E Bermes
Impact of biotechnology in the diagnostic and therapeutic management of cardiovascular disorders.
Advances in experimental medicine and biology 1995;369():99-110.
1994: B Kaiser; Walter P Jeske; Debra Hoppensteadt; Jawed Fareed
Inhibitory effects of TFPI variants on thrombin and factor Xa generation in fibrinogen-deficient human plasma.
Thrombosis research 1994;76(6):561-8.
1994: Jeanine M Walenga; Jawed Fareed
Automation and quality control in the coagulation laboratory.
Clinics in laboratory medicine 1994;14(4):709-28.
1994: B Kaiser; Debra A Hoppensteadt; Walter P Jeske; T C Wun; Jawed Fareed
Inhibitory effects of TFPI on thrombin and factor Xa generation in vitro--modulatory action of glycosaminoglycans.
Thrombosis research 1994;75(6):609-16.
1994: Jawed Fareed; D Hoppensteadt; Jeanine M Walenga; Rodger L Bick
Current trends in the development of anticoagulant and antithrombotic drugs.
The Medical clinics of North America 1994;78(3):713-31.
1994: DD Callas; P Bacher; Omer Iqbal; Debra Hoppensteadt; Jawed Fareed
Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.
Thrombosis research 1994;74(3):193-205.
1994: R Kijowski; Debra Hoppensteadt; Jeanine M Walenga; Lars C Borris; M R Lassen; Jawed Fareed
Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparin.
Thrombosis research 1994;74(1):53-64.
1994: R Kijowski; Debra Hoppensteadt; Walter P Jeske; Jawed Fareed
Protamine sulfate neutralization of the anticoagulant activity of Aprosulate, a synthetic sulfated lactobionic acid amide.
Thrombosis research 1994;73(5):349-59.
1994: B Kaiser; DD Callas; Debra Hoppensteadt; K Mallinowska; Jawed Fareed
Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems.
Thrombosis research 1994;73(5):327-35.
1994: A Ahsan; Walter P Jeske; J Mardiguian; Jawed Fareed
Feasibility study of heparin mass calibrator as a GPC calibrator for heparins and low molecular weight heparins.
Journal of pharmaceutical sciences 1994;83(2):197-201.
1993: Debra Hoppensteadt; Walter P Jeske; Jawed Fareed
Pharmacological profile of reviparin-sodium.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1993;4 Suppl 1():S11-6.
1993: P Bacher; Jeanine M Walenga; Omer Iqbal; S Bajusz; K Breddin; Jawed Fareed
The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models.
Thrombosis research 1993;71(4):251-63.
1993: P Bacher; Omer Iqbal; B Lojewski; Jeanine M Walenga; Ferdinand Leya; Jawed Fareed
A simulated post-angioplasty low molecular weight heparin schedule in a non-human primate model.
Thrombosis research 1993;70(4):295-306.
1993: P Bacher; G Kindel; Jeanine M Walenga; Jawed Fareed
Modulation of endothelial and platelet function by a polydeoxyribonucleotide derived drug "defibrotide". A dual mechanism in the control of vascular pathology.
Thrombosis research 1993;70(4):343-8.
1993: Walter P Jeske; A Ahsan; Jawed Fareed
Molecular weight profiling of low molecular weight heparins utilizing a heparinase degraded oligosaccharide mixture as a calibrator.
Thrombosis research 1993;70(1):39-50.
1993: D M Najman; Jeanine M Walenga; Jawed Fareed; R Pifarré
Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgery.
The Annals of thoracic surgery 1993;55(3):662-6.
1993: DD Callas; A Ahsan; Omer Iqbal; Jawed Fareed
Molecular weight and biochemical profile of a chemically modified heparin derivative, Suleparoide.
Thrombosis research 1993;69(4):369-76.
1993: L Iyer; M Koza; Omer Iqbal; R Calabria; Jawed Fareed
Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs.
Thrombosis research 1993;69(3):259-69.
1993: L Iyer; Jordan A Shavit; M Koza; R Calabria; S Moran; Jawed Fareed
Alteration of pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after repeated intravenous administration in dogs.
Thrombosis research 1993;69(1):59-70.
1993: P Bacher; B Horst; H G Breyer; Debra A Hoppensteadt; Jeanine M Walenga; Jawed Fareed
Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patients.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():73-8.
1993: A Ahsan; Walter P Jeske; Jawed Fareed
Validation of the European Pharmacopeial method for molecular weight profiling of low molecular weight heparins: comparative studies utilizing an improved calibrator, ITH-3.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():63-8.
1993: Krystyna Malinowska; Omer Iqbal; Debra A Hoppensteadt; Jeanine M Walenga; Jawed Fareed
In vivo study of bleeding and antithrombotic effects of low molecular weight heparin ML-009723.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():58-62.
1993: B Lojewski; P Bacher; Omer Iqbal; Jeanine M Walenga; Debra A Hoppensteadt; Ferdinand Leya; Jawed Fareed
Evaluation of hematologic alterations associated with daily administration of low molecular weight heparin (Mono-Embolex) for a 12-week period.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():36-43.
1993: Debra A Hoppensteadt; S Haas; H K Breddin; Jawed Fareed
Modulation of laboratory parameters after therapeutic and prophylactic administration of Sandoparin.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():31-5.
1993: Walter P Jeske; B Lojewski; Jeanine M Walenga; Debra Hoppensteadt; A Ahsan; Jawed Fareed
Biochemical and pharmacologic profile of low molecular weight heparin (LU 47311, Clivarin).
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():229-40.
1993: Omer Iqbal; Walter P Jeske; P Bacher; Debra A Hoppensteadt; Jeanine M Walenga; Jawed Fareed
A comparison of the pharmacokinetic and pharmacodynamic profiles of Clexane and Lovenox in dogs.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():199-209.
1993: Jawed Fareed; Debra A Hoppensteadt; Jeanine M Walenga
Current perspectives on low molecular weight heparins.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():1-11.
1993: M J Koza; Jeanine M Walenga; Jawed Fareed; R Pifarre
A new approach in monitoring recombinant hirudin during cardiopulmonary bypass.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():90-6.
1993: DD Callas; Debra A Hoppensteadt; Walter P Jeske; Omer Iqbal; P Bacher; A Ahsan; Jawed Fareed
Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():49-57.
1993: Walter P Jeske; Jawed Fareed
Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analogues.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():241-7.
1993: Debra A Hoppensteadt; Walter P Jeske; A Ahsan; Jeanine M Walenga; Jawed Fareed
Biochemical and pharmacologic profile of defined molecular weight fractions of heparin.
Seminars in thrombosis and hemostasis 1993;19 Suppl 1():12-9.
1992: Jawed Fareed; D Hoppenstedt; R L Bick; P Bacher
Drug-induced alterations of hemostasis and fibrinolysis.
Hematology/oncology clinics of North America 1992;6(6):1229-45.
1992: A Racanelli; Jawed Fareed
Neutralization of the antithrombotic effects of heparin and Fraxiparin by protamine sulfate.
Thrombosis research 1992;68(3):211-22.
1992: Debra Hoppensteadt; Jeanine M Walenga; Jawed Fareed
Low molecular weight heparins. An objective overview.
Drugs & aging 1992;2(5):406-22.
1992: A Racanelli; Jawed Fareed
Ex vivo activity of heparin is not predictive of blood loss after neutralization by protamine.
Thrombosis research 1992;67(2):263-73.
1992: Jawed Fareed; P Bacher; Harry L Messmore; Jeanine M Walenga; Debra A Hoppensteadt; A Strano; R Pifarre
Pharmacological modulation of fibrinolysis by antithrombotic and cardiovascular drugs.
Progress in cardiovascular diseases 1992;34(6):379-98.
1992: Jeanine M Walenga; Debra Hoppensteadt; Jawed Fareed; R Pifarré
Hemostatic abnormalities in total artificial heart patients as detected by specific blood markers.
The Annals of thoracic surgery 1992;53(5):844-50.
1992: P Bacher; D Welzel; Omer Iqbal; Debra Hoppensteadt; DD Callas; Jeanine M Walenga; Jawed Fareed
The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model.
Thrombosis research 1992;66(2-3):151-8.
1991: Jawed Fareed; Jeanine M Walenga; Ferdinand Leya; P Bacher; Debra Hoppensteadt; Harry L Messmore; R Pifarre
Some objective considerations for the use of heparins and recombinant hirudin in percutaneous transluminal coronary angioplasty.
Seminars in thrombosis and hemostasis 1991;17(4):455-70.
1991: Jawed Fareed
Venous thromboprophylaxis in the 1990s: a perspective.
Seminars in thrombosis and hemostasis 1991;17(4):317-21.
1991: Jawed Fareed; Jeanine M Walenga; Debra Hoppensteadt; L Iyer; R Pifarre
Neutralization of recombinant hirudin: some practical considerations.
Seminars in thrombosis and hemostasis 1991;17(2):137-44.
1991: Jeanine M Walenga; Debra Hoppensteadt; M Koza; R Pifarre; Jawed Fareed
Comparative studies on various assays for the laboratory evaluation of r-hirudin.
Seminars in thrombosis and hemostasis 1991;17(2):103-12.
1991: Mali Mathru; DJ Dries; A Zecca; Jawed Fareed; M W Rooney; T L Rao
Effect of fast vs slow intralipid infusion on gas exchange, pulmonary hemodynamics, and prostaglandin metabolism.
Chest 1991;99(2):426-9.
1991: Jeanine M Walenga; Mamdouh Bakhos; Harry L Messmore; Jawed Fareed; R Pifarre
Potential use of recombinant hirudin as an anticoagulant in a cardiopulmonary bypass model.
The Annals of thoracic surgery 1991;51(2):271-7.
1991: Jawed Fareed; Jeanine M Walenga; L Iyer; Debra Hoppensteadt; R Pifarre
An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(1):135-47.
1991: Jeanine M Walenga; Mamdouh Bakhos; Harry L Messmore; M Koza; M Wallock; E Orfei; Jawed Fareed; R Pifarre
Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass model.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(1):105-11.
1991: T Hubbard; T Olivier; P Bacher; Jeanine M Walenga; H Galal; Jawed Fareed; R Pifarre
Use of recombinant hirudin to increase the patency rate of microanastomosis in a rabbit model.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1991;2(1):101-3.
1991: Debra A Hoppensteadt; Jeanine M Walenga; Jawed Fareed
Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.
Seminars in thrombosis and hemostasis 1991;17 Suppl 1():60-4.
1991: Jawed Fareed; Debra Hoppensteadt; Jeanine M Walenga; A Ahsan; E Coyne; H K Breddin
Molecular and functional heterogeneity in dermatan sulfate preparations.
Seminars in thrombosis and hemostasis 1991;17 Suppl 2():174-80.
1991: Debra Hoppensteadt; Jeanine M Walenga; Jawed Fareed
Protamine sulfate neutralization of lactobionic acid amides.
Seminars in thrombosis and hemostasis 1991;17 Suppl 2():153-7.
1991: Jawed Fareed; S Coker; Omer Iqbal; Debra Hoppensteadt; Jeanine M Walenga
Pharmacodynamics of a sulfated lactobionic acid amide-derived antithrombotic agent (Aprosulate) in primates.
Seminars in thrombosis and hemostasis 1991;17 Suppl 2():147-52.
1991: Jawed Fareed; Jeanine M Walenga; R Pifarre; Debra Hoppensteadt; M Koza
Some objective considerations for the neutralization of the anticoagulant actions of recombinant hirudin.
Haemostasis 1991;21 Suppl 1():64-72.
1991: Jeanine M Walenga; Debra Hoppensteadt; M Koza; M Wallock; R Pifarre; Jawed Fareed
Laboratory assays for the evaluation of recombinant hirudin.
Haemostasis 1991;21 Suppl 1():49-63.
1991: Jeanine M Walenga; Debra Hoppensteadt; Jawed Fareed
Non-heparin glycosaminoglycan-derived drugs: a biochemical and pharmacologic perspective.
Seminars in thrombosis and hemostasis 1991;17 Suppl 2():137-42.
1991: Stanley Lorens; M Guschwan; N Hata; Louis D Van De Kar; Jeanine M Walenga; Jawed Fareed
Behavioral, endocrine, and neurochemical effects of sulfomucopolysaccharide treatment in the aged Fischer 344 male rat.
Seminars in thrombosis and hemostasis 1991;17 Suppl 2():164-73.
1991: Harry L Messmore; B Griffin; M Koza; J Seghatchian; Jawed Fareed; E Coyne
Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.
Seminars in thrombosis and hemostasis 1991;17 Suppl 1():57-9.
1991: Jawed Fareed; Jeanine M Walenga; Debra Hoppensteadt; Lars C Borris; M R Lassen
Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin).
Seminars in thrombosis and hemostasis 1991;17 Suppl 3():319-28.
1991: Jeanine M Walenga; Debra Hoppensteadt; Jawed Fareed
Laboratory monitoring of the clinical effects of low molecular weight heparins.
Thrombosis research. Supplement 1991;14():49-62.
1990: Debra Hoppensteadt; Jeanine M Walenga; Jawed Fareed
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparin.
Thrombosis research 1990;60(3):191-200.
1990: Vijaya B Reddy; A Kowal-Vern; Debra A Hoppensteadt; A Kumar; Jeanine M Walenga; Jawed Fareed; H R Schumacher
Global and molecular hemostatic markers in acute myeloid leukemia.
American journal of clinical pathology 1990;94(4):397-403.
1990: Jawed Fareed; Jeanine M Walenga; M Lassen; Lars C Borris; Debra Hoppensteadt; R Murphy; A Ahsan; S Weber; L N Jorgensen; O Hauch
Pharmacologic profile of a low molecular weight heparin (enoxaparin): experimental and clinical validation of the prophylactic antithrombotic effects.
Acta chirurgica Scandinavica. Supplementum 1990;556():75-90.
1989: Jawed Fareed; Jeanine M Walenga; Debra Hoppensteadt; A Racanelli; E Coyne
Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardization.
Seminars in thrombosis and hemostasis 1989;15(4):440-63.
1989: A Racanelli; Debra A Hoppensteadt; Jawed Fareed
In vitro protamine neutralization profiles of heparins differing in source and molecular weight.
Seminars in thrombosis and hemostasis 1989;15(4):386-9.
1989: Debra Hoppensteadt; A Racanelli; Jeanine M Walenga; Jawed Fareed
Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparin.
Seminars in thrombosis and hemostasis 1989;15(4):378-85.
1989: Jeanine M Walenga; R Pifarre; Debra A Hoppensteadt; Jawed Fareed
Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerations.
Seminars in thrombosis and hemostasis 1989;15(3):316-33.
1989: Jawed Fareed; Jeanine M Walenga; U Cornelli
Antithrombotic drugs in pelvic surgery.
Seminars in thrombosis and hemostasis 1989;15(2):230-2.
1989: Jawed Fareed; Jeanine M Walenga; Debra Hoppensteadt; X Huan; R Nonn
Biochemical and pharmacologic inequivalence of low molecular weight heparins.
Annals of the New York Academy of Sciences 1989;556():333-53.
1989: Harry L Messmore; B Griffin; Jawed Fareed; E Coyne; J Seghatchian
In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets.
Annals of the New York Academy of Sciences 1989;556():217-32.
1988: Jeanine M Walenga; M Petitou; M Samama; Jawed Fareed; J Choay
Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activity.
Thrombosis research 1988;52(6):553-63.
1988: E Coyne; Jeanine M Walenga; Jawed Fareed
Aggregates in heparin.
Journal of pharmaceutical sciences 1988;77(9):818-20.
1988: Jeanine M Walenga; L Bara; M Petitou; M Samama; Jawed Fareed; J Choay
The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity.
Thrombosis research 1988;51(1):23-33.
1988: J J Choate; D R Domenico; T P McGraw; Jawed Fareed; Z Molnar; H R Schumacher
Diagnosis of acute megakaryoblastic leukemia by flow cytometry and immunoalkaline phosphatase techniques. Utilization of new monoclonal antibodies.
American journal of clinical pathology 1988;89(2):247-53.
1988: R M Emanuele; A Racanelli; Jawed Fareed
Pharmacokinetics of heparins differing in mean molecular weight using a Xa amidolytic and Heptest clotting method.
Therapeutic drug monitoring 1988;10(2):153-9.
1988: Jawed Fareed; Jeanine M Walenga; A Racanelli; Debra Hoppensteadt; X Huan; H L Messmore
Validity of the newly established low-molecular-weight heparin standard in cross-referencing low-molecular-weight heparins.
Haemostasis 1988;18 Suppl 3():33-47.
1988: Jawed Fareed; Jeanine M Walenga; Debra Hoppensteadt; X Huan; A Racanelli
Comparative study on the in vitro and in vivo activities of seven low-molecular-weight heparins.
Haemostasis 1988;18 Suppl 3():3-15.
1988: Jawed Fareed; Jeanine M Walenga; Debra A Hoppensteadt; A Kumar; O N Ulutin; U Cornelli
Pharmacologic profiling of defibrotide in experimental models.
Seminars in thrombosis and hemostasis 1988;14 Suppl():27-37.
1987: R M Emanuele; Jawed Fareed
The effect of molecular weight on the bioavailability of heparin.
Thrombosis research 1987;48(5):591-6.
1987: Jawed Fareed
[Low molecular weight heparin fractions. Comparative preclinical study of various parameters].
Journal des maladies vasculaires 1987;12 Suppl B():59-63.
1985: A Racanelli; Jawed Fareed; Jeanine M Walenga; E Coyne
Biochemical and pharmacologic studies on the protamine interactions with heparin, its fractions and fragments.
Seminars in thrombosis and hemostasis 1985;11(2):176-89.
1984: Jawed Fareed; R Moncada; Harry L Messmore; J M Walenga; Debra Hoppensteadt; William H Wehrmacher
Molecular markers of contrast media-induced adverse reactions.
Seminars in thrombosis and hemostasis 1984;10(4):306-28.
1983: Jawed Fareed; R L Bick; G Squillaci; Jeanine M Walenga; E W Bermes
Molecular markers of hemostatic disorders: implications in the diagnosis and therapeutic management of thrombotic and bleeding disorders.
Clinical chemistry 1983;29(9):1641-58.
1983: Jawed Fareed; H L Messmore; Jeanine M Walenga; E W Bermes
Diagnostic efficacy of newer synthetic-substrates methods for assessing coagulation variables: a critical overview.
Clinical chemistry 1983;29(2):225-36.
1983: Jawed Fareed; H L Messmore; Jeanine M Walenga; E W Bermes
Synthetic peptide substrates in hemostatic testing.
Critical reviews in clinical laboratory sciences 1983;19(2):71-134.
1982: Jawed Fareed; H L Messmore; Jeanine M Walenga; E W Bermes; R L Bick
Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.
Seminars in thrombosis and hemostasis 1982;8(4):288-301.
1980: Jawed Fareed; H L Messmore; E W Bermes
New perspectives in coagulation testing.
Clinical chemistry 1980;26(10):1380-91.